Section Arrow
Quote
NOTV.NASDAQ
- Inotiv
Quotes are at least 15-min delayed:2025/09/17 16:59 EDT
After Hours
Last
 1.33
0 (0.00%)
Bid
1.32
Ask
1.39
High 1.33 
Low 1.33 
Volume 504 
Regular Hours
Last
 1.33
-0.02 (-1.48%)
Day High 
1.375 
Prev. Close
1.35 
1-M High
1.92 
Volume 
813.39K 
Bid
1.32
Ask
1.39
Day Low
1.27 
Open
1.34 
1-M Low
1.26 
Market Cap 
46.38M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.5 
20-SMA 1.61 
50-SMA 1.84 
52-W High 6.48 
52-W Low 1.15 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.62/--
Enterprise Value
476.19M
Balance Sheet
Book Value Per Share
4.19
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
490.74M
Operating Revenue Per Share
16.95
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies0.1826-0.0784-30.04%-- 
After Hours 0.1805 -0.0021 -1.15%
NEOGNeogen Corp5.46+0.19+3.61%879PE
After Hours 5.46 0 0.00%
DHRDanaher Corp192.94+2.47+1.30%40.44PE
After Hours 193.25 +0.31 +0.16%
NEONeoGenomics8.11+0.12+1.50%-- 
After Hours 8.06 -0.05 -0.62%
CHEKCheck-Cap Ltd2.32-0.2-7.94%-- 
After Hours 2.37 +0.05 +2.16%
Quotes are at least 15-min delayed：2025/09/17 16:59 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.